Cigna Corp (NYSE:CI) CEO David Cordani Buys 32,509 Shares

Share on StockTwits

Cigna Corp (NYSE:CI) CEO David Cordani bought 32,509 shares of Cigna stock in a transaction on Monday, September 9th. The shares were acquired at an average price of $155.17 per share, for a total transaction of $5,044,421.53.

Shares of CI stock opened at $161.89 on Thursday. The company has a market cap of $61.70 billion, a P/E ratio of 11.38, a PEG ratio of 0.83 and a beta of 0.73. The firm has a fifty day moving average price of $160.99 and a 200 day moving average price of $161.69. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.84. Cigna Corp has a 12 month low of $141.95 and a 12 month high of $226.60.

Cigna (NYSE:CI) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.56. The company had revenue of $34.38 billion for the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a return on equity of 13.24% and a net margin of 3.60%. Cigna’s quarterly revenue was up 198.9% on a year-over-year basis. During the same period last year, the firm earned $3.89 earnings per share. On average, equities analysts forecast that Cigna Corp will post 16.75 EPS for the current year.

Several equities analysts have commented on the stock. ValuEngine cut shares of Cigna from a “hold” rating to a “sell” rating in a research report on Tuesday, July 23rd. Stephens set a $225.00 price objective on Cigna and gave the stock a “buy” rating in a research report on Friday, August 23rd. Morgan Stanley reduced their price objective on Cigna from $241.00 to $207.00 and set an “overweight” rating on the stock in a research note on Friday, July 12th. Citigroup reiterated a “buy” rating on shares of Cigna in a report on Wednesday, August 21st. Finally, Sanford C. Bernstein raised Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 target price for the company in a research note on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $215.39.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nuveen Asset Management LLC raised its position in shares of Cigna by 1,351.4% during the 2nd quarter. Nuveen Asset Management LLC now owns 2,334,509 shares of the health services provider’s stock worth $367,802,000 after acquiring an additional 2,173,662 shares in the last quarter. FMR LLC increased its stake in Cigna by 21.6% in the first quarter. FMR LLC now owns 12,229,261 shares of the health services provider’s stock valued at $1,966,710,000 after purchasing an additional 2,171,463 shares during the last quarter. Geode Capital Management LLC increased its stake in Cigna by 61.3% in the fourth quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock valued at $936,405,000 after purchasing an additional 1,876,556 shares during the last quarter. Nordea Investment Management AB raised its holdings in Cigna by 23.8% during the first quarter. Nordea Investment Management AB now owns 3,565,966 shares of the health services provider’s stock worth $573,487,000 after purchasing an additional 686,132 shares in the last quarter. Finally, Ruffer LLP raised its holdings in Cigna by 41.7% during the first quarter. Ruffer LLP now owns 1,839,179 shares of the health services provider’s stock worth $295,804,000 after purchasing an additional 541,087 shares in the last quarter. Institutional investors and hedge funds own 87.46% of the company’s stock.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: Beige Book

Insider Buying and Selling by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Clal Insurance Enterprises Holdings Ltd Has $13.35 Million Stock Holdings in DBX ETF TR/X-TRACKERS MSCI JAP
Clal Insurance Enterprises Holdings Ltd Has $13.35 Million Stock Holdings in DBX ETF TR/X-TRACKERS MSCI JAP
ISHARES TR/3-7 YR TREAS BD ETF  is Lyons Wealth Management LLC.’s 2nd Largest Position
ISHARES TR/3-7 YR TREAS BD ETF is Lyons Wealth Management LLC.’s 2nd Largest Position
Nanometrics  Lifted to Hold at BidaskClub
Nanometrics Lifted to Hold at BidaskClub
Nasdaq  Downgraded by BidaskClub
Nasdaq Downgraded by BidaskClub
NetScout Systems  Raised to “Hold” at BidaskClub
NetScout Systems Raised to “Hold” at BidaskClub
Intellia Therapeutics  Raised to Hold at BidaskClub
Intellia Therapeutics Raised to Hold at BidaskClub


© 2006-2019 Ticker Report